Story perspectives

AVA-003: A Game Changer in Fighting Antimicrobial Resistance

10/1/2025

38 4

Summary

Story summary

AvantGuard's AVA-003 offers sustained pathogen activity, addressing antimicrobial resistance in healthcare and Ukraine.
AVA-003 demonstrates uniform lethality against resistant and susceptible bacteria and fungi.
Its selective targeting enables safe surface disinfection and wound treatment without harming tissue.
The rise of pan-resistant Klebsiella pneumoniae among Ukrainian war victims underscores urgent infection prevention and stewardship needs, especially in agriculture, which accounts for significant global antibiotic use.

1 of 1

Story summary

AvantGuard's AVA-003 offers sustained pathogen activity, addressing antimicrobial resistance in healthcare and Ukraine.
AVA-003 demonstrates uniform lethality against resistant and susceptible bacteria and fungi.
Its selective targeting enables safe surface disinfection and wound treatment without harming tissue.
The rise of pan-resistant Klebsiella pneumoniae among Ukrainian war victims underscores urgent infection prevention and stewardship needs, especially in agriculture, which accounts for significant global antibiotic use.